Physician profile

Serrie Lico

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Las Vegas, NV

NPI 1790746790

$14,205.84

in general payments reported to CMS, 2019-2025

39 companies · $2,849 in 2025

The $2,849 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,503.93
Travel and Lodging$967.42

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Atricure, INC. $3,814.24 2019-2024
Medtronic Vascular, INC. $3,158.38 2019-2020
Abbott Laboratories $1,959.59 2019-2024 Navitor, Epic, Cardiomems
Edwards Lifesciences Corporation $959.28 2020-2025 Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve
Medtronic, INC. $951.65 2021-2025 Avalus, Endurant Iis, Penditure
Abiomed $683.99 2019-2025 Impella
Artivion, INC. $460.92 2019-2025 Amds-Ascyrus Medical
Cvrx, INC. $307.05 2024-2025 Barostim Neo System
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $283.00 2019-2023 Lifevest
Boehringer Ingelheim Pharmaceuticals, INC. $186.41 2019-2023 Jardiance
Amgen INC. $173.04 2019-2023 Repatha
Bolton Medical INC $169.38 2025 Thoraflex Hybrid
Janssen Pharmaceuticals, INC $158.19 2019-2022
Ethicon US, LLC $121.33 2021-2025 Echelon Endopath, Echelon; Endopath
Astrazeneca Pharmaceuticals LP $100.34 2019-2020
Show all 39 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $91.17 2019-2022
Zimmer Biomet Holdings, INC. $83.23 2019-2022
Biom'Up Sa $73.15 2019
Kls-Martin L.P. $66.53 2019-2025
Davol INC. $54.72 2019-2023 Progel Applicator Spray Tips
Cleerly, INC. $49.55 2025 Cleerly Ischemia, Cleerly Labs
Lexicon Pharmaceuticals, INC. $46.44 2023 Inpefa
Lsi Solutions INC $24.18 2019-2020
Biosense Webster, INC. $23.54 2023 Octaray Mapping Catheter
Terumo Medical Corporation $20.10 2023 Glidesheath Slender
Livanova USA, INC. $19.68 2023 Lifesparc
Amarin Pharma, INC. $18.40 2019
Lundbeck LLC $16.54 2019
Actelion Pharmaceuticals US, INC. $15.86 2023 Opsumit, Uptravi
Astellas Pharma US INC $15.36 2019
Boston Scientific Corporation $14.05 2025 Cds - Mct/Cem Monitoring
Rock Medical Orthopedics, INC. $13.96 2021
Kowa Pharmaceuticals America, INC. $12.88 2020
Becton, Dickinson and Company $12.80 2023 Progel Applicator Spray Tips
Bayer Healthcare Pharmaceuticals INC. $12.71 2023
Regeneron Healthcare Solutions, INC. $12.20 2019
Pfizer INC. $11.70 2019
Z-Medica, LLC $7.09 2019
Elutia, INC. $3.21 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Serrie Lico

$14,205.84

in general payments reported 2019-2025

Years
2019-2025
Top company
Atricure, INC.
Context
The $2,849 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/171798/serrie-lico

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.